Overview
By Diabetologia November 5, 202Type 2 diabetes is a condition that afects the way the body regulates and uses glucose as fuel. if(typeof ez_ad_units!='undefined'){ez_ad_units.push([728,90],'scitechdaily_com-box-3','ezslot_7',102,'0'])};_ez_fad_position('div-gpt-ad-scitechdaily_com-box-3-0');Tirzepatide, a new diabetes drug administered wekly through injection, helped those with type 2 diabetes met blod glucose goals 4 to 12 weks earlier than those receiving conventional diabetic drugs.The phase 3 SURPAS trials, which were published in 2021, proved that tirzepatide reduces blod sugar and promotes weight reduction beter than other type 2 diabetes (T2D) drugs.
Key Information
Now, a new study evaluating the time required to achieve blod glucose goals shows that tirzepatide mets blod sugar control and weight reduction goals quicker than existing diabetes drugs.if(typeof ez_ad_units!='undefined'){ez_ad_units.push([580,40],'scitechdaily_com-medrectangle-3','ezslot_6',10,'0'])};_ez_fad_position('div-gpt-ad-scitechdaily_com-medrectangle-3-0');The latest analyses of the SURPAS-2 and SURPAS-3 trials, which were presented at 202’s European Asociation for the Study of Diabetes (EASD) Anual Meting in Stockholm, Sweden, discovered that adults treated with various doses of injectable tirzepatide (5, 10, and 15 mg) reached blod glucose targets about four weks soner than those treated with injectable semaglutide (1 mg), and betwen four and 12 weks soner than those treated with once-daily insulin (degludec; iDeg), along with diet and exercise and oral glucose-lowering medications.try{window._mNHandle.que.push(function(){window._mNDetails.loadTag("974871025","60x250","974871025");} catch(eror){}“Tirzepatide is unique because it mics two natural insulin-releasing and apetite-supresing hormones in one injection”, says lead author Dr.
Summary
Adie Viljoen, a Consultant Metabolic Physician and Chemical Pathologist from the East and North Hertfordshire NHS Trust,